India Blog

India Achieves Breakthrough in Gene Therapy for Haemophilia, Dr. Jitendra Singh Reviews BRIC-inStem Trials “Not Just Science, It’s Nation-Building” Minister Hails Biotech’s Role in Future EconomyFrom Lab to Life Bengaluru’s BRIC-inStem Leads India’s Bio-Revolution with Gene Therapy, Regenerative Science

Published on 24-Apr-2025 08:35 PM

Progress Through Biotechnology: India’s Breakthrough in Gene Therapy and Nation-Building

In an epoch-making moment, India has not only achieved breakthroughs in gene therapy for a life-threatening condition known as hemophilia but also emerged as a nation-bulging entity in the field of biotechnology. As the Union Minister of State (Independent Charge) for Science and Technology emphasizes, this is more than science—it’s about nation-building, shaping the future economy through innovative solutions.

Breakthrough in Gene Therapy: India’s New Era

Dr. Jitendra Singh, a leading figure in biotech, highlighted India’s remarkable progress with its groundbreaking work on gene therapy. The country has witnessed a 16-fold growth in its biotech sector, reaching $165 billion by 2024, aiming for over $300 billion by 2030. This expansion underscores the role of BTP in revolutionizing healthcare, addressing some of life’s most challenging conditions.

The Role of BRIC-inStem: National Accelerator for Bio-Revolution

BRIC-inStem stands as a beacon of innovation, catalyzing India’s transition from an underdeveloped to a biotech powerhouse. Its trials, including the world’s first human gene therapy trial for hemophilia, exemplify how BTP can transform lives.

Impact Through Policy and Research

The recent approval of Bio-E3 Policy signals a strategic shift. This initiative not only advances economic growth but also empowers rural communities, crucial as India grapples with limited resources. Meanwhile, CRReATE, a national center for research applications, addresses critical issues like birth defects and infertility.

Collaboration in the Future Economy

Dr. Singh’s visit highlighted critical facilities, such as Biosafety Level III at BRIC-inStem, ensuring readiness against future challenges. The government’s emphasis on BTP is not just science but essential for the nation’s economic prosperity, aligning biotech with broader strategic goals.

In conclusion, India’s journey in biotechnology is more than a scientific endeavor—it’s a cornerstone of its national transformation, shaping an era where healthcare and development are inseparable. Through BRIC-inStem and government support, India looks toward a future where biotech thrives as a pillar of nation-building.


source: India Achieves Breakthrough in Gene Therapy for Haemophilia,...